-
Balancing Fit and Accuracy: Evaluating Survival Model Projections With Immature Data in Health Technology Assessments
Sep 9, 2025, 16:22 PM -
Revisiting Rarity: Would Yesterday’s NICE Highly Specialized Technologies Still Qualify Today?
Sep 9, 2025, 16:22 PM -
Hospitalization and Healthcare Consumption Burden of Respiratory Syncytial Virus (RSV) in Adults Over 50 years in France (RESVYR Study)
Sep 9, 2025, 16:22 PM -
Children With Asthma Receiving Dupilumab Plus Medium-Dose Inhaled Corticosteroids Had Improved Exacerbations, Lung Function, and Airway Inflammation Compared To Those Receiving Placebo Plus High-Dose Inhaled Corticosteroids
Sep 9, 2025, 16:22 PM -
Limited Access to Joint Scientific Consultations in 2025: Strategic Impact on Industry and Policy Directions for Sustainable EU HTA Implementation
Sep 9, 2025, 16:22 PM -
Analytical Modeling in Economic Evaluations of Obesity Interventions to Inform Health Policy: A Narrative Review
Sep 9, 2025, 16:22 PM -
Disease Management Costs in Late-Line Metastatic Colorectal Cancer: A Portuguese Perspective Using Structured Expert Elicitation
Sep 9, 2025, 16:22 PM -
The Cost of Pressure: Quantifying the Consequences of Clinical Strain in Ophthalmology
Sep 9, 2025, 16:22 PM -
Analysis of the Breast Cancer Diagnosis Program: A Window of Opportunity
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of Coblation Intracapsular Tonsillectomy in the Management of Sleep-Disordered Breathing and Recurrent Tonsillitis: A Brazilian Perspective
Sep 9, 2025, 16:22 PM -
Rising EAP Rejection Rates and Their Impact on Drug Access in France
Sep 9, 2025, 16:22 PM -
Incidence of Neutropenia Adverse Events Identified in Electronic Healthcare Records Among Initiators of CDK4/6 Inhibitors With Advanced Breast Cancer in the UK
Sep 9, 2025, 16:22 PM -
Healthcare Resource Utilization and Economic Burden Among Caregivers of Individuals With Autism Spectrum Disorder Caregiver: Findings From the 2024 5EU National Health and Wellness Survey
Sep 9, 2025, 16:22 PM -
Cost-Consequence and Clinical Impact of NGS Testing in Advanced Lung Adenocarcinoma: Real-World Evidence From a Portuguese Public Hospital
Sep 9, 2025, 16:22 PM -
Molecular Testing Strategies and Their Impact on Treatment Decision in HR+/HER2- Metastatic Breast Cancer: A Real-World Analysis From German Centers
Sep 9, 2025, 16:22 PM -
Pharmacovigilance of Cannabis-Based Products in Brazil
Sep 9, 2025, 16:22 PM -
A Review of Indirect Costs Within Economic Appraisals in France
Sep 9, 2025, 16:22 PM -
Importance of Decisional Context in the Health Technology Assessment (HTA) of Advanced Therapy Medicinal Products (ATMPs)
Sep 9, 2025, 16:22 PM -
Budget Impact Analysis of STRIDE (Tremelimumab + Durvalumab) vs. Atezolizumab + Bevacizumab for Unresectable Hepatocellular Carcinoma: Qatari Payer and Societal Perspectives
Sep 9, 2025, 16:22 PM -
Workforce Matters: Defining Labor Input for Better Health Technology Assessment
Sep 9, 2025, 16:22 PM
